Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

AdapTherapy

AdapTherapy?uq=iauh9QUh
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Provider of a vitro diagnostic multivariate index assay intended to improve healthcare for everyone through personalized and precise information. The company's product, Premed is a vitro diagnostic multivariate index assay which permits the determination of therapeutically targetable dominant signaling pathways in the cancer sample and predicts the effectiveness of targeted therapies for individual patient treatment, enabling clinicians to get confidence to select the appropriate individual therapeutic strategy.

Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Primary Office
  • Parc d'Innovation
  • 650 Boulevard Gonthier d'Andernach
  • 67400 Illkirch-Graffenstaden
  • France
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore AdapTherapy’s full profile, request a free trial.

AdapTherapy Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator Completed Generating Revenue
1. Angel (individual) Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

AdapTherapy Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
SEMIA Incubateur d' Alsace Accelerator/Incubator Minority 000 0000 000000 0

AdapTherapy Executive Team (1)

Name Title Board
Seat
Contact
Info
Bertrand Loubaton Chief Executive Officer